The XV Molecular Cytopathology Meeting, December 9-10, 2026, Naples, Italy
Submission Deadline, October 1, 2026
We invite all trainee, junior, and early-in-practice Pathology and/or Cytopathology professionals to submit an abstract for a platform presentation the XV Molecular Cytopathology Meeting to be held on December 9-10, 2026, in Naples, Italy.
Abstracts may be based on Cytology cases with molecular correlates that aided in diagnosis or treatment decisions or Cytopathology research pertaining to molecular diagnostics. Abstracts submitted by a trainee are encouraged to include a senior pathologist as a mentor.
All abstracts selected by the Scientific Committee will have an in-person platform presentation at the XV Molecular Cytopathology Meeting.
General Information
1. All abstracts must be submitted by October 1, 2026.
2. Verify your information carefully before submitting (i.e., spelling, email address, etc.). The submitter will receive a Confirmation of Receipt email.
3. All authors listed for an abstract must complete a conflict of interest. It is the responsibility of the First Author to make sure that all Conflict of Interest (COI) disclosures have been completed.
4. Submission of an abstract constitutes a commitment by at least one author to present at the XV Molecular Cytopathology Meeting, if accepted. The presenter will need to register for the meeting and present in person. No travel expenses or accommodation will be provided, and it is the responsibility of the presenter to make all arrangements to attend the meeting in person.
5. Abstracts should be no longer than 300 words in length and written in paragraphs with clearly identified headings: Introduction, Materials and Methods, Results, and Conclusions.
6. Abstracts must be original and not previously published, nor currently accepted for publication or presentation at another meeting, to be eligible for consideration.
7. The criteria for scoring will include scientific validity, originality, academic importance, study design, and style.